Do Top Fund Managers Measure Up?: Part 1

Recs

3

With thousands of mutual funds to choose from, finding a handful of great funds rivals the proverbial needle in the haystack. That's why so many business publications create annual lists of the best funds and fund managers around. Barron's recently joined the fray, releasing its annual ranking of the top 100 fund managers, compiled from Value Line data. Below, we'll take a magnifying glass to Barron's top 10 manager picks, and determine whether you should own any of these funds.

Aegis Value (AVALX)
Topping Barron's fund rankings is manager Scott Barbee, skipper of the Aegis Value Fund. This fund focuses on the smaller end of the market-cap spectrum, currently holding roughly 70% of its portfolio in micro-cap stocks. Barbee takes a deep value approach to selecting attractive small companies. Aegis Value is somewhat concentrated, with almost all of its holdings in just five sectors. The fund also has a history of holding tremendously high levels of cash, including a 54% stake back in 2004, when assets were flooding into the fund. Partly because of the fund's high cash stake, Aegis Value has lagged the Russell 2000 Index for the past three calendar years, and it's trailing year to date through August.

Assets have started returning to the fund once again, after shareholders withdrew hundreds of millions of dollars in the wake of the fund's lagging performance. In fact, the fund's five-year return through August places it in the bottom quartile of its peer group. While this fund may make sense for investors seeking a strong value fund that invests mainly in micro-cap stocks, Aegis Value may not be appropriate for most Fools. If you're seeking broad small-cap exposure, consider looking elsewhere.

Black Rock International Opportunity (BREAX)
This closed fund is managed by senior portfolio manager Thomas Callan and co-manager Michael Carey. Black Rock International Opportunity lands in the foreign small/mid growth category, according to Morningstar. The fund's managers combine macroeconomic factors with quantitative screens and fundamental analysis to identify small- and mid-cap foreign stocks with the highest return potential. The fund has posted some impressive absolute returns in its 10-year history, including an eye-popping 151% return in 1999. Of course, foreign small-caps have been on a tear the past few years, so don't expect this fund to continue producing such spectacular gains in the future.

International Opportunity is a bit on the pricey side, with a 1.62% net expense ratio. However, there are only a few dozen funds that focus on small-cap foreign companies, so the field is somewhat limited. If you already own this fund, it shouldn't be the sole source of your international exposure. Make sure you also stock up on a fund that invests in larger foreign companies as well.

CGM Focus Fund (CGMFX)
Next on the Barron's rankings is a rather aggressive equity fund run by longtime manager Ken Heebner. CGM Focus invests in both foreign and domestic stocks, such as current top holdings Vimpel Communications (NYSE: VIP), Schlumberger (NYSE: SLB), and Fluor (NYSE: FLR). This fund is not for the faint of heart. Focus Fund is extremely concentrated, with 75% of assets in just two sectors -- industrial materials and energy. It also sports a high 333% annual turnover rate, and it can sell stocks short in addition to holding long positions.

So far, Heebner's aggressive bets have worked out well for the fund. CGM Focus posted a 54% return in 2000, when most stocks lost money, and it returned an impressive 66% in 2003. The fund is also ahead of the S&P 500 by more than 33% so far this year. But its brash style may not always be in favor. A wrong move or a blown market call could absolutely pummel this fund. If you have a taste for high risk, CGM Focus might fit the bill. But it's probably too spicy for most investors, so keep an eye out for a tamer broad-market equity fund.

Our series continues in Part 2, with reviews of more of Barron's top fund managers.

Related articles:

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 537264, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:34:36 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
FLR $48.01 Up +2.61 +5.75%
Fluor Corp (NEW) CAPS Rating: *****
SLB $65.13 Up +0.73 +1.13%
Schlumberger, Limi… CAPS Rating: *****
VIP $20.58 Up +1.39 +7.22%
Vimpel-Communicati… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!